Liver solid space-occupying lesions

I believe that many people do not know what kind of disease solid space-occupying lesions of the liver are. From the surface meaning, it is a liver disease, but it is recommended that everyone understand what kind of symptoms this liver disease will cause in the liver. The presence of solid space-occupying lesions in the liver can lead to diseases such as cirrhosis and chronic hepatitis, which can be detected through B-ultrasound.

What is a liver space-occupying lesion?

Liver space-occupying lesions is a technical term in medical imaging diagnosis, usually appearing in the results of upper abdominal B-ultrasound, CT, and MRI examinations. It generally refers to the presence of "extra things" in the examined liver: including tumors (both benign and malignant), stones, cysts, abscesses, parasites, etc. It is not a synonym for liver cancer.

Benign and malignant

Hepatic space-occupying lesions can be divided into malignant hepatic space-occupying lesions and benign hepatic space-occupying lesions according to their nature.

Malignant

Malignant space-occupying lesions of the liver include hepatocellular carcinoma, cholangiocarcinoma, liver metastasis, hepatic sarcoma, etc.

benign

Benign space-occupying lesions of the liver can generally be divided into two types: cystic space-occupying lesions and solid space-occupying lesions. The former mainly include liver cysts, liver abscesses, echinococcosis, etc.; the latter mainly include hepatic hemangioma, focal nodular hyperplasia, focal fatty liver, hepatocellular adenoma, hepatic inflammatory pseudotumor, adenomatous hyperplasia, etc.

What should I do if I find a liver space-occupying lesion?

If you find a space-occupying lesion in the liver, don't panic. First, you should find a specialist to make a qualitative and definite diagnosis. The diagnosis should be made based on a comprehensive analysis of the medical history, physical signs, laboratory tests, and imaging examinations. For malignant tumors, early detection, early diagnosis and early treatment are necessary; for benign lesions, regular check-ups are required to monitor the size and changes. If there is a history of hepatitis B virus infection or if the patient is a chronic hepatitis B patient, close observation is required.

To determine whether it is liver cancer, alpha-fetoprotein is currently the most specific marker for diagnosing hepatocellular carcinoma. Monitoring this indicator can help determine whether the space-occupying lesions are benign or malignant.